- Home
- FCAP vs PRME Comparison
FCAP vs PRME Comparison
Compare FCAP & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCAP | PRME |
|---|---|---|
| Founded | 1891 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.9M | 601.1M |
| IPO Year | 1999 | 2022 |
Fundamental Metrics
Financial Performance| Metric | FCAP | PRME |
|---|---|---|
| Price | $64.60 | $4.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.31 |
| AVG Volume (30 Days) | 7.9K | ★ 3.7M |
| Earning Date | 01-23-2026 | 11-07-2025 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | ★ 25.19 | N/A |
| EPS | ★ 4.41 | N/A |
| Revenue | ★ $47,323,000.00 | $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.55 | ★ N/A |
| Revenue Growth | 15.22 | ★ 647.13 |
| 52 Week Low | $28.50 | $1.11 |
| 52 Week High | $65.86 | $6.94 |
Technical Indicators
Market Signals| Indicator | FCAP | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 84.11 | 52.01 |
| Support Level | $47.48 | $3.95 |
| Resistance Level | $59.98 | $4.42 |
| Average True Range (ATR) | 2.29 | 0.30 |
| MACD | 1.40 | 0.12 |
| Stochastic Oscillator | 96.91 | 76.72 |
Price Performance
Historical ComparisonAbout FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.